Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Arteriovenous MalformationHereditary Hemorrhagic TelangiectasiaHematocheziaMelena
Interventions
DRUG

Thalidomide

Thalidomide 50 - 200 mg once at nightime

Trial Locations (3)

11768

Northport VAMC, Northport

30912

Medical College of Georgia, Augusta

01655

UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

Augusta University

OTHER

collaborator

University of Massachusetts, Worcester

OTHER

lead

Northport Veterans Affairs Medical Center

FED

NCT00389935 - Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding | Biotech Hunter | Biotech Hunter